Marìa Isabel Martín Herranz

Marìa Isabel Martín Herranz


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
VGVíctor Giménez-Arufe
Víctor Giménez-Arufe
SRSandra Rotea-Salvo
Sandra Rotea-Salvo
APAlejandro Martínez Pradeda
Alejandro Martínez Pradeda
ÁMÁlvaro Mena-De-Cea
Álvaro Mena-De-Cea
LMLuis Margusino-Framiñán
Luis Margusino-Framiñán
PCPURIFICACIÓN CID-SILVA
PURIFICACIÓN CID-SILVA
Early diagnosis of a Human Immunodeficiency Virus (HIV)-infected person represents a cornerstone of HIV prevention, treatment, and care. Numerous publications have developed recommendations where HIV serology is indicated to reduce missed diagnostic opportunities (MDOs). This retrospective study analyses new HIV infection diagnoses and the relationship between late diagnosis (LD)/advanced HIV disease (AHD), baseline characteristics, and MDOs. Sociodemographic data and data related to contact with the health system in the 5 years before diagnosis were collected. Most of the 273 diagnoses were made in primary care (48.5%). Approximately 50.5% and 34.4% had LD and AHD criteria, respectively. Female sex was associated with a higher incidence of LD. Persons infected through the heterosexual route and those at an older age had a higher risk for LD and AHD. People with previous HIV serology presented a lower percentage of LD and AHD. In total, 10% of the health contact instances were classified as MDOs, mostly occurring in primary care. A significant increase in the median of MDOs was observed in patients with LD/AHD. Female sex and hepatitis C virus co-infection were associated with an increase in the number of MDOs. The high percentage of LD and AHD and the significant number of MDOs show that the current screening system should be improved.

21 April 2023 in Farmacia Hospitalaria
Verified
Journal Article
Open access
APAlejandro Martínez Pradeda
Alejandro Martínez Pradeda
MPMaría Sandra Albiñana Pérez
María Sandra Albiñana Pérez
COCarla Fernández Oliveira
Carla Fernández Oliveira
ALAna Díaz Lamas
Ana Díaz Lamas
MAMarta Rey Abalo
Marta Rey Abalo
MHMarìa Isabel Martín Herranz
Marìa Isabel Martín Herranz
The aim of this study was to determine whether the transition of care from the intensive care unit to the ward would pose a high risk for reconciliation errors. The primary outcome of this study was to describe and quantify the discrepancies and reconciliation errors. Secondary outcomes included classification of the reconciliation errors by type of medication error, therapeutic group of the drugs involved and grade of potential severity. We conducted a retrospective observational study of reconciliated adult patients discharged from the Intensive Care Unit to the ward. Before a patient was discharged from the intensive care unit, their last intensive care unit's prescriptions were compared with their proposed medication list in the ward. The discrepancies between these were classified as justified discrepancies or reconciliation errors. Reconciliation errors were classified by type of error, potential severity, and therapeutic group. We found that 452 patients were reconciliated. At least one discrepancy was detected in 34.29% (155/452), and 18.14% (82/452) had at least one reconciliation errors. The most found error types were a different dose or administration route (31.79% (48/151)) and omission errors (31.79% (48/151)). High alert medication was involved in 19.20% of reconciliation errors (29/151). Our study shows that intensive care unit to non-intensive care unit transitions are high-risk processes for reconciliation error. They frequently occur and occasionally involve high alert medication, and their severity could require additional monitoring or cause temporary harm. Medication reconciliation can reduce reconciliation errors.

10 April 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
APAlejandro Martínez Pradeda
Alejandro Martínez Pradeda
LELaida Elberdín
Laida Elberdín
ÁPÁngeles Porta-Sánchez
Ángeles Porta-Sánchez
MOMaría Outeda
María Outeda
MPMª Teresa Diz-Lois Palomares
Mª Teresa Diz-Lois Palomares
MHMarìa Isabel Martín Herranz
Marìa Isabel Martín Herranz
Measuring biological drugs’ trough concentrations and the concentrations of anti-drug antibodies is a valuable practice for treatment optimization. ELISA techniques are the gold standard for biological drug concentration quantification, but new techniques such as chemiluminescence immunoassays present some advantages. The aim of this unicentric prospective observational study is to compare the infliximab, adalimumab, vedolizumab and ustekinumab trough levels and anti-adalimumab and anti-infliximab antibodies concentrations obtained when using a chemiluminescent instrument (i-TRACK®, Theradiag, Croissy-Beaubourg, France) and an ELISA instrument (TRITURUS®, Griffols, Barcelona, Spain). Linear regression, Pearson or Spearman tests, Bland–Altman plots and the Cohen kappa test were applied for every sample. The correlation was excellent for both assays in the measurement of all drug concentrations. In general, values were lower when measured using i-TRACK than when using TRITURUS, especially when the values were high. Both techniques proved valuable in clinical practice for monitoring adalimumab and infliximab drug concentration. However, the results were modest for ustekinumab and vedolizumab, so caution is recommended and further research is needed. The limited number of anti-drug antibody-positive samples precluded a comparison between the techniques.

1 July 2021
Verified
Journal Article
Closed access
MGMarta Garcia-Queiruga
Marta Garcia-Queiruga
CFCarla Fernandez-Oliveira
Carla Fernandez-Oliveira
MMMaria Jose Mauriz-Montero
Maria Jose Mauriz-Montero
APAngeles Porta-Sanchez
Angeles Porta-Sanchez
LMLuis Margusino-Framiñán
Luis Margusino-Framiñán
MHMarìa Isabel Martín Herranz
Marìa Isabel Martín Herranz

1 July 2014 in Revista de Calidad Asistencial
Verified
Journal Article
Closed access
MRM.T. Rabuñal-Álvarez
M.T. Rabuñal-Álvarez
MCM. Calvin-Lamas
M. Calvin-Lamas
BFB. Feal-Cortizas
B. Feal-Cortizas
LML.M. Martínez-López
L.M. Martínez-López
IPI. Pedreira-Vázquez
I. Pedreira-Vázquez
MHMarìa Isabel Martín Herranz
Marìa Isabel Martín Herranz